Murine T cell activation is regulated by surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide).

Biochem Biophys Res Commun

Department of Pathology, Dalhousie University, Tupper Building, 5850 College Street, Halifax, Nova Scotia B3H 4R2, Canada; Department of Microbiology & Immunology, Dalhousie University, Tupper Building, 5850 College Street, Halifax, Nova Scotia B3H 4R2, Canada; Department of Surgery (Neurosurgery), Dalhousie University, Tupper Building, 5850 College Street, Halifax, Nova Scotia B3H 4R2, Canada. Electronic address:

Published: January 2014

AI Article Synopsis

  • Surfen binds to glycosaminoglycans (GAGs) and impacts their function, influencing T cell activation and proliferation.
  • Surfen administration in mice showed a dose-dependent reduction in T cell proliferation and lymph node cell counts, while also affecting specific receptor expression but not overall cell viability.
  • Interestingly, when T cell activation was bypassed, surfen's effect shifted to either a neutral or stimulatory response, suggesting a complex role for GAGs and proteoglycans in T cell activity.

Article Abstract

Surfen (bis-2-methyl-4-amino-quinolyl-6-carbamide) binds to glycosaminoglycans (GAGs) and has been shown to influence their function, and the function of proteoglycans (complexes of GAGs linked to a core protein). T cells synthesize, secrete and express GAGs and proteoglycans which are involved in several aspects of T cell function. However, there are as yet no studies on the effect of GAG-binding agents such as surfen on T cell function. In this study, surfen was found to influence murine T cell activation. Doses between 2.5 and 20 μM produced a graduated reduction in the proliferation of T cells activated with anti-CD3/CD28 antibody-coated T cell expander beads. Surfen (20 mg/kg) was also administered to mice treated with anti-CD3 antibody to activate T cells in vivo. Lymphocytes from surfen-treated mice also showed reduced proliferation and lymph node cell counts were reduced. Surfen reduced labeling with a cell viability marker (7-ADD) but to a much lower extent than its effect on proliferation. Surfen also reduced CD25 (the α-subunit of the interleukin (IL)-2 receptor) expression with no effect on CD69 expression in T cells treated in vivo but not in vitro. When receptor activation was bypassed by treating T cells in vitro with phorbyl myristate acetate (10 ng/ml) and ionomycin (100 ng/ml), surfen treatment either increased proliferation (10 μM) or had no effect (2.5, 5 and 20 μM). In vitro treatment of T cells with surfen had no effect on IL-2 or interferon-γ synthesis and did not alter proliferation of the IL-2 dependent cell line CTLL-2. The effect of surfen was antagonized dose-dependently by co-treatment with heparin sulfate. We conclude that surfen inhibits T cell proliferation in vitro and in vivo. When T cell receptor-driven activation is bypassed surfen had a neutral or stimulatory effect on T cell proliferation. The results imply that endogenous GAGs and proteoglycans play a complex role in promoting or inhibiting different aspects of T cell activation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2013.11.119DOI Listing

Publication Analysis

Top Keywords

cell activation
12
surfen
12
cell
11
murine cell
8
surfen bis-2-methyl-4-amino-quinolyl-6-carbamide
8
gags proteoglycans
8
aspects cell
8
cell function
8
surfen reduced
8
activation bypassed
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!